Apyx Medical Corp Debt Securities, Available-for-sale, Amortized Cost
Apyx Medical Corp (APYX) had Debt Securities, Available-for-sale, Amortized Cost of $73.14 million as of 2019-03-31, per its 10-Q/A filed 2020-05-08.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2020-05-08
- 2019-03-31: Debt Securities, Available-for-sale, Amortized Cost $73.14M.
- 2018-12-31: Debt Securities, Available-for-sale, Amortized Cost $78.03M; Debt Securities, Available-for-sale, Amortized Cost as first filed $77.90M.
- 2018-09-30: Debt Securities, Available-for-sale, Amortized Cost $96.10M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2019-03-31 | $73.14M 10-Q/A · filed 2020-05-08 | |
| 2018-12-31 | $78.03M 10-Q/A · filed 2020-05-08 | $77.90M 10-K · filed 2019-03-14 |
| 2018-09-30 | $96.10M 10-Q/A · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |